Intracellular targets for antidiabetic sulfonylureas and potassium channel openers
- 1 November 1997
- journal article
- review article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 54 (9) , 961-965
- https://doi.org/10.1016/s0006-2952(97)00136-6
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Glibenclamide inhibits mitochondrial K+ and Na+ uniports induced by magnesium depletionThe International Journal of Biochemistry & Cell Biology, 1996
- The Mitochondrial K Channel as a Receptor for Potassium Channel OpenersJournal of Biological Chemistry, 1996
- Reconstitution of I KATP : An Inward Rectifier Subunit Plus the Sulfonylurea ReceptorScience, 1995
- The Role of Mitochondrial Potassium Fluxes in Controlling the Protonmotive Force in Energized MitochondriaBiochemical and Biophysical Research Communications, 1995
- Potassium Channel Opener, RP 66471, Induces Membrane Depolarization of Rat Liver MitochondriaBiochemical and Biophysical Research Communications, 1995
- Glibenclamide stimulates growth of human chondrocytes by IGF I dependent mechanismsExperimental and Clinical Endocrinology & Diabetes, 1995
- The sulfonylurea receptorBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1992
- Pancreatic and Extrapancreatic Sulfonylurea ReceptorsHormone and Metabolic Research, 1992
- TMB-8 (8-(N,N-diethylamino) octyl-3,4,5-trimethoxybenzoate) inhibits the ATP-sensitive K+ channelEuropean Journal of Pharmacology: Molecular Pharmacology, 1992
- Sulphonylurea Antidiabetic DrugsDrugs, 1989